NIH-funded study shows less diabetic retinopathy progression among those who underwent intensive glycemic control
Bethesda, Maryland–(ENEWSPF)–June 13, 2016. People with type 2 diabetes who intensively controlled their blood sugar level during the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study were found to have cut their risk of diabetic retinopathy in half in a follow-up analysis conducted four years after stopping intensive therapy. Investigators who led the ACCORD Follow-on Eye Study…
